Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric

Accurate clinical assessment of a patient's response to treatment for glioblastoma multiforme (GBM), the most malignant type of primary brain tumor, is undermined by the wide patient-to-patient variability in GBM dynamics and responsiveness to therapy. Using computational models that account fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Maxwell Lewis, Trister, Andrew D., Cloke, Tyler, Sodt, Rita, Ahn, Sunyoung, Baldock, Anne L., Bridge, Carly A., Lai, Albert, Cloughesy, Timothy F., Mrugala, Maciej M., Rockhill, Jason K., Rockne, Russell C., Swanson, Kristin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553125/
https://www.ncbi.nlm.nih.gov/pubmed/23372647
http://dx.doi.org/10.1371/journal.pone.0051951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553125/
https://www.ncbi.nlm.nih.gov/pubmed/23372647
http://dx.doi.org/10.1371/journal.pone.0051951

Ejemplares similares